N | 1220 (2.3%) | 51 357 (97.7%) |
Pneumonia 1997–2001 | 277 (1.8%) | 15 011 (98.2%) |
Pneumonia 2002–2006 | 411 (2.3%) | 17 657 (97.7%) |
Pneumonia 2007–2011 | 532 (2.8%) | 18 674 (97.2%) |
Age, median | 74 (66–80) | 72 (59–81) |
16–39 years | 18 (1.5%) | 4406 (8.6%) |
40–49 years | 35 (2.9%) | 3311 (6.5%) |
50–59 years | 120 (9.8%) | 5739 (11.2%) |
60–69 years | 249 (20.4%) | 8890 (17.3%) |
70–79 years | 454 (37.2%) | 13 176 (25.7%) |
80–89 years | 306 (25.1%) | 12 699 (24.7%) |
90–105 years | 38 (3.1%) | 3136 (6.1%) |
Sex |
Women | 801 (65.7%) | 24 018 (46.8%) |
Men | 419 (34.3%) | 27 339 (53.2%) |
Comorbidity |
Congestive heart failure | 170 (13.9%) | 5269 (10.3%) |
Peripheral vascular disease | 118 (9.7%) | 3811 (7.4%) |
Previous myocardial infarction | 104 (8.5%) | 3443 (6.7%) |
Chronic pulmonary disease | 291 (23.9%) | 10 431 (20.3%) |
Cerebrovascular disease | 174 (14.3%) | 6936 (13.5%) |
Haemiplegia | 5 (0.4%) | 335 (0.7%) |
Dementia | 17 (1.4%) | 1246 (2.4%) |
Connective tissue disease | 109 (8.9%) | 1425 (2.8%) |
Peptic ulcer disease | 118 (9.7%) | 3064 (6.0%) |
Diabetes 1 and 2 | 106 (8.7%) | 4024 (7.8%) |
Diabetes with end organ damage | 65 (5.3%) | 2155 (4.2%) |
Moderate to severe renal disease | 83 (6.8%) | 1967 (3.8%) |
Any tumour | 146 (12.0%) | 6914 (13.5%) |
Leukaemia | 13 (1.1%) | 670 (1.3%) |
Lymphoma | 21 (1.8%) | 1160 (2.3%) |
Metastatic solid tumour | 32 (2.6%) | 1568 (3.1%) |
Mild liver disease | 16 (1.3%) | 757 (1.5%) |
Moderate-to-severe liver disease | 4 (0.3%) | 231 (0.5%) |
AIDS | <3 | 70 (0.1%) |
Alcoholism-related disorders | 17 (1.4%) | 2411 (4.7%) |
Comorbidity Index (level of Charlson Index Score) |
Low (0) | 391 (32.1%) | 21 487 (41.8%) |
Medium (1–2) | 543 (44.5%) | 19 514 (38.0%) |
High (≥3) | 286 (23.4%) | 10 356 (20.2%) |
Duration of hospital stay, median | 6 (3–10) | 6 (3–10) |
Systemic antibiotic therapy before admission | 445 (36.5%) | 17 094 (33.3%) |